Movatterモバイル変換

[0]ホーム

Jump to content

CTOP

Add links

From Wikipedia, the free encyclopedia

Selective mu-opioid receptor antagonist peptide

On Wikipedia, CTOP may refer toWikipedia:Contentious topics.

CTOP
Names

IUPAC name (4S,7R,10S,13R,16S,19R)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-10-(3-aminopropyl)-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-3,3-dimethyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
Identifiers
CAS Number	103429-31-8
3D model (JSmol)	Interactive image
ChEBI	CHEBI:230371
ChemSpider	4470595
KEGG	C20160
PubChem CID	5311058
InChI InChI=1S/C50H67N11O11S2/c1-26(62)39(42(53)65)59-49(72)41-50(3,4)74-73-25-38(58-43(66)33(52)21-28-11-6-5-7-12-28)47(70)56-36(22-29-16-18-31(64)19-17-29)45(68)57-37(23-30-24-54-34-14-9-8-13-32(30)34)46(69)55-35(15-10-20-51)44(67)60-40(27(2)63)48(71)61-41/h5-9,11-14,16-19,24,26-27,33,35-41,54,62-64H,10,15,20-23,25,51-52H2,1-4H3,(H2,53,65)(H,55,69)(H,56,70)(H,57,68)(H,58,66)(H,59,72)(H,60,67)(H,61,71)/t26-,27-,33-,35+,36+,37-,38+,39+,40+,41-/m1/s1 Key: PZWWYAHWHHNCHO-FGHAYEPSSA-N
SMILES C(C=1C=2C(NC1)=CC=CC2)[C@H]3NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@@H](NC([C@@H](CC5=CC=CC=C5)N)=O)CSSC(C)(C)[C@@H](C(N[C@@H]([C@@H](C)O)C(N)=O)=O)NC(=O)[C@]([C@@H](C)O)(NC(=O)[C@H](CCCN)NC3=O)[H]
Properties
Chemical formula	C₅₀H₆₇N₁₁O₁₁S₂
Molar mass	1062.27 g·mol⁻¹
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). Infobox references

Chemical compound

CTOP is anopioid antagonist cyclic peptide related tosomatostatin.^[1] It has been used in research about other opioid ligands.^[2]^[3]

Pharmacology

[edit]

CTOP is described as a highly potent mu-opioid receptor antagonist. In mice, its analgesic effects are qualified as being more potent than naloxone's, a well-known opioid antagonist typically used as an antidote in humans.^[4] Additionally, CTOP appears to lack significant affinity at the delta and kappa opioid receptors, suggesting that this peptide is selective for the µ receptor.^[5]

References

[edit]

^PubChem."Phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide".pubchem.ncbi.nlm.nih.gov. Retrieved2026-01-01.
^Soini, S. L.; Ovaska, T.; Honkanen, A.; Hyytiä, P.; Korpi, E. R. (April 1998). "Brain opioid receptor binding of [3H]CTOP and [3H]naltrindole in alcohol-preferring AA and alcohol-avoiding ANA rats".Alcohol (Fayetteville, N.Y.).15 (3):227–232.doi:10.1016/s0741-8329(97)00125-0.ISSN 0741-8329.PMID 9539380.
^Leite dos Santos, Gisele Graça; Casais e Silva, Luciana Lyra; Pereira Soares, Milena Botelho; Villarreal, Cristiane Flora (November 2012)."Antinociceptive properties of Micrurus lemniscatus venom".Toxicon.60 (6):1005–1012.Bibcode:2012Txcn...60.1005L.doi:10.1016/j.toxicon.2012.07.003.ISSN 1879-3150.PMID 22841808.
^Gulya, K.; Kriván, M.; Nyolczas, N.; Sarnyai, Z.; Kovács, G. L. (1988-06-10). "Central effects of the potent and highly selective mu opioid antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) in mice".European Journal of Pharmacology.150 (3):355–360.doi:10.1016/0014-2999(88)90018-0.ISSN 0014-2999.PMID 2901358.
^Hawkins, K. N.; Knapp, R. J.; Gehlert, D. R.; Lui, G. K.; Yamamura, M. S.; Roeske, L. C.; Hruby, V. J.; Yamamura, H. I. (1988). "Quantitative autoradiography of [3H]CTOP binding to mu opioid receptors in rat brain".Life Sciences.42 (25):2541–2551.doi:10.1016/0024-3205(88)90322-0.ISSN 0024-3205.PMID 2898716.